Delivery Order SPE2DR25D3301-SPE2DR26F19MM
- Not listed
- The Defense Logistics Agency awarded a $10.7K delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 60 units. This non-competitive delivery order, with a firm fixed price structure, is scheduled for completion by January 5, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,590.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of LONSURF (20 mg–8.19 mg tablets in quantities of 20) with completion scheduled for December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on demonstrated capability. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $10,248.32 and firm fixed pricing. The contract is non-set-aside and represents a competitively awarded delivery order, with an ultimate completion date of November 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.92 to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (quantity 20) on October 20, 2025, with completion expected by November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,539.15 to AmerisourceBergen Drug Corp for LONSURF 15 mg-6.14 mg tablets (20-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order, which represents a single transaction under the company's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 10, 2025, valued at $14,361.52 for the supply of LONSURF 20 mg-8.19 mg tablets in quantities of 20. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance to be completed by January 2, 2026, and fulfillment at the company's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of LONSURF 15 mg-6.14 mg tablets (60-count units) with a ceiling value of $8,099.15. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded...
- The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19MMDelivery Order
The Defense Logistics Agency awarded a $14.2K delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for LONSURF 20 mg-8.19 mg tablets (40-count supply) with completion targeted for January 6, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. Performance will occur at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for LONSURF, an oncology medication, exemplifies the breadth of specialized pharmaceutical products the contractor furnishes through its DLA supply agreement, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 12/11/25 |